Estimated cause-specific survival continues to improve over time in patients with chondrosarcoma

Clinical Orthopaedics and Related Research

Volumn 472, Issue 8, 2014, Pages 2516-2525

  Duchman, Kyle R ^a   Lynch, Charles F ^b   Buckwalter, Joseph A ^a   Miller, Benjamin J ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; CHONDROSARCOMA; CONTROLLED STUDY; FOLLOW UP; HUMAN; LIFE TABLE; LIMB TUMOR; MAJOR CLINICAL STUDY; MIDDLE AGED; NATIONAL HEALTH ORGANIZATION; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR DIAGNOSIS; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CHONDROSARCOMA; HUMANS; LIFE TABLES; MIDDLE AGED; NEOPLASM GRADING; RISK FACTORS; SEER PROGRAM; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84904087808     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-014-3600-3     Document Type: Article

References (42)

1. Aarons C, Potter BK, Adams SC, Pitcher JD Jr, Temple HT. Extended intralesional treatment versus resection of low-grade chondrosarcomas. Clin Orthop Relat Res. 2009;467:2105-2111.
2. Ambs A, Warren JL, Bellizzi KM, Topor M, Haffer SC, Clauser SB. Overview of the SEER-Medicare Health Outcomes Survey linked dataset. Health Care Financ Rev. 2008;29:5-21.
3. Angelini A, Guerra G, Mavrogenis AF, Pala E, Picci P, Ruggieri P. Clinical outcome of central conventional chondrosarcoma. J Surg Oncol. 2012;106:929-937.
4. Bach PB, Guadagnoli E, Schrag D, Schussler N, Warren JL. Patient demographic and socioeconomic characteristics in the SEER-Medicare database-applications and limitations. Med Care. 2002;40:19-25.
5. Bjornsson J, McLeod RA, Unni KK, Ilstrup DM, Pritchard DJ. Primary chondrosarcoma of long bones and limb girdles. Cancer. 1998;83:2105-2119. (Pubitemid 28525392)
6. Bleyer A, Choi M, Fuller CD, Thomas CR Jr, Wang SJ. Relative lack of conditional survival improvement in young adults with cancer. Semin Oncol. 2009;36:460-467.
7. Choi M, Fuller CD, Thomas CR Jr, Wang SJ. Conditional survival in ovarian cancer: results from the SEER dataset 1988-2001. Gynecol Oncol. 2008;109:203-209.
8. Damron TA, Ward WG, Stewart A. Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report. Clin Orthop Relat Res. 2007;459:40-47. (Pubitemid 46878192)
9. Davis FG, McCarthy BJ, Freels S, Kupelian V, Bondy ML. The conditional probability of survival of patients with primary malignant brain tumors - Surveillance, Epidemiology and End Results (SEER) data. Cancer. 1999;85:485-491. (Pubitemid 29051306)
10. Donati D, Colangeli S, Colangeli M, Di Bella C, Bertoni F. Surgical treatment of grade I central chondrosarcoma. Clin Orthop Relat Res. 2010;468:581-589.
11. Fiorenza F, Abudu A, Grimer RJ, Carter SR, Tillman RM, Ayoub K, Mangham DC. Risk factors for survival and local control in chondrosarcoma of bone. J Bone Joint Surg Br. 2002;84:93-99. (Pubitemid 34105631)
12. Fritz A, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S, eds. International Classification of Diseases for Oncology, 3rd Revision. Geneva, Switzerland: World Health Organization; 2000.
13. Fuller CD, Wang SJ, Thomas CR Jr, Hoffman HT, Weber RS, Rosenthal DI. Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973-1998. Cancer. 2007;109:1331-1343. (Pubitemid 46466560)
14. Gelderblom H, Hogendoorn PC, Dijkstra SD, van Rijswijk CS, Krol AD, Taminiau AH, Bovee JV. The clinical approach towards chondrosarcoma. Oncologist. 2008;13:320-329. (Pubitemid 351679908)
15. Gitelis S, Bertoni F, Picci P, Campanacci M. Chondrosarcoma of bone. The experience at the Istituto Ortopedico Rizzoli. J Bone Joint Surg Am. 1981;63:1248-1257. (Pubitemid 11022301)
16. Giuffrida AY, Burgueno JE, Koniaris LG, Gutierrez JC, Duncan R, Scully SP. Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. J Bone Joint Surg Am. 2009;91:1063-1072.
17. Johnson DR, Ma DJ, Buckner JC, Hammack JE. Conditional probability of long-term survival in glioblastoma: a population-based analysis. Cancer. 2012;118:5608-5613.
18. Krochak R, Harwood AR, Cummings BJ, Quirt IC. Results of radical radiation for chondrosarcoma of bone. Radiother Oncol. 1983;1:109-115. (Pubitemid 14182310)
19. Lee FY, Mankin HJ, Fondren G, Gebhardt MC, Springfield DS, Rosenberg AE, Jennings LC. Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am. 1999;81:326-338. (Pubitemid 29153210)
20. Leerapun T, Hugate RR, Inwards CY, Scully SP, Sim FH. Surgical management of conventional grade I chondrosarcoma of long bones. Clin Orthop Relat Res. 2007;463:166-172. (Pubitemid 47585267)
21. Lin PP, Alfawareh MD, Takeuchi A, Moon BS, Lewis VO. Sixty percent 10-year survival of patients with chondrosarcoma after local recurrence. Clin Orthop Relat Res. 2012;470:670-676.
22. Marcove RC, Mike V, Hutter RV, Huvos AG, Shoji H, Miller TR, Kosloff R. Chondrosarcoma of the pelvis and upper end of the femur. An analysis of factors influencing survival time in one hundred and thirteen cases. J Bone Joint Surg Am. 1972;54:561-572.
23. McNaney D, Lindberg RD, Ayala AG, Barkley HT, Hussey DH. Fifteen year radiotherapy experience with chondrosarcoma of bone. Int J Radiat Oncol Biol Phys. 1982;8:187-190. (Pubitemid 12139892)
24. Merrill RM, Henson DE, Barnes M. Conditional survival among patients with carcinoma of the lung. Chest. 1999;116:697-703. (Pubitemid 29428487)
25. Merrill RM, Hunter BD. Conditional survival among cancer patients in the United States. Oncologist. 2010;15:873-882.
26. Miller BJ, Lynch CF, Buckwalter JA. Conditional survival is greater than overall survival at diagnosis in patients with osteosarcoma and Ewing's sarcoma. Clin Orthop Relat Res. 2013;471:3398-3404.
27. Mohler DG, Chiu R, McCall DA, Avedian RS. Curettage and cryosurgery for low-grade cartilage tumors is associated with low recurrence and high function. Clin Orthop Relat Res. 2010;468:2765-2773.
28. National Cancer Institute. National Cancer Institute Fact Sheet. Available at: http://www.cancer.gov/cancertopics/factsheet/disparities/cancer- health-disparities. Accessed June 3, 2013.
29. National Comprehensive Cancer Network. Available at: www.nccn.org/index. asp. Accessed December 28, 2012.
30. Nattinger AB, McAuliffe TL, Schapira MM. Generalizability of the Surveillance, Epidemiology, and End Results Registry population: factors relevant to epidemiologic and health care research. J Clin Epidemiol. 1997;50:939-945. (Pubitemid 27423524)
31. Parsons HM, Habermann EB, Tuttle TM, Al-Refaie WB. Conditional survival of extremity soft-tissue sarcoma: results beyond the staging system. Cancer. 2011;117:1055-1060.
32. Pring ME, Weber KL, Unni KK, Sim FH. Chondrosarcoma of the pelvis. A review of sixty-four cases. J Bone Joint Surg Am. 2001;83:1630-1642.
33. Rizzo M, Ghert MA, Harrelson JM, Scully SP. Chondrosarcoma of bone: analysis of 108 cases and evaluation for predictors of outcome. Clin Orthop Relat Res. 2001;391:224-233. (Pubitemid 32954068)
34. Rueth NM, Groth SS, Tuttle TM, Virnig BA, Al-Refaie WB, Habermann EB. Conditional survival after surgical treatment of melanoma: an analysis of the Surveillance, Epidemiology, and End Results database. Ann Surg Oncol. 2010;17:1662-1668.
35. Skeletal Lesions Interobserver Correlation among Expert Diagnosticians Study Group. Reliability of histopathologic and radiologic grading of cartilaginous neoplasms in long bones. J Bone Joint Surg Am. 2007;89:2113-2123.
36. Soderstrom M, Ekfors TO, Bohling TO, Teppo LH, Vuorio EI, Aro HT. No improvement in the overal survival of 194 patients with chondrosarcoma in Finland in 1971-1990. Acta Orthop Scand. 2003;74:344-350. (Pubitemid 36890744)
37. Staals EL, Bacchini P, Bertoni F. Dedifferentiated central chondrosarcoma. Cancer. 2006;106:2682-2691.
38. Wang SJ, Emery R, Fuller CD, Kim JS, Sittig DF, Thomas CR. Conditional survival in gastric cancer: a SEER database analysis. Gastric Cancer. 2007;10:153-158. (Pubitemid 47547297)
39. Wang SJ, Fuller CD, Emery R, Thomas CR. Conditional survival in rectal cancer: a SEER database analysis. Gastrointest Cancer Res. 2007;1:84-89.
40. Wyman JJ, Hornstein AM, Meitner PA, Mak S, Verdier P, Block JA, Pan J, Terek RM. Multidrug resistance-1 and P-glycoprotein in human chondrosarcoma cell lines: expression correlates with decreased intracellular doxorubicin and in vitro chemoresistance. J Orthop Res. 1999;17:935-940.
41. Xing Y, Chang GJ, Hu CY, Askew RL, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Lucci A, Cormier JN. Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis. Cancer. 2010;116:2234-2241.
42. Yu XQ, Baade PD, O'Connell DL. Conditional survival of cancer patients: an Australian perspective. BMC Cancer. 2012;12:460.